Beyond Type 1 Names Tracey McCarter as Interim CEO
SAN MATEO, Calif., Dec. 9, 2021 – Beyond Type 1 announced today the appointment of Tracey McCarter, a member of the organization’s Board of Directors, as interim CEO of the global nonprofit. McCarter has served on Beyond Type 1’s Board of Directors since 2018, and prior to that, served on the organization’s Leadership Council since its inception in 2015. She has been a dedicated philanthropist to the type 1 diabetes community since 2009 when her daughter was diagnosed with type 1 diabetes.
“Tracey is a remarkable individual that I have had the privilege of knowing for the last three years,” said Beyond Type 1 Board Chairman Nate Checketts. “I have been impressed by her acumen, her attention to detail and, most importantly, the way she cares fiercely for this team and our cause.”
McCarter’s appointment follows the unexpected passing of former CEO and president, Thom Scher. Thom served as Beyond Type 1’s first COO and was elevated to the helm of the organization in 2018.
“Tracey is a trusted member of our team, and Thom often shared what an asset she is to the organization,” said Checketts. “Thom was an outstanding leader, colleague and friend to many. While it’s difficult to imagine anyone filling his shoes, I have confidence Tracey will be the leader this organization needs now to heal and continue serving the Type 1 community.”
McCarter earned her Master of Business Administration at the University of Southern California. She also serves on the Spouse/Partner Community Board for the Young Presidents’ Organization (YPO). She resides in Arizona with her husband and two daughters.
About Beyond Type 1
Beyond Type 1 is a nonprofit organization changing what it means to live with diabetes. By leveraging the power of social media and technology, Beyond Type 1 empowers people to both live well today and support a better tomorrow. Through peer support programs, global campaigns and digital platforms, Beyond Type 1 is uniting the global diabetes community across both Type 1 and Type 2 diabetes, helping to change what it means to live with chronic illness.